EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Low-Grade Cervical Intraepithelial Neoplasia (CIN1) Evolution: Analysis of Opportunistic Preventive Vaccination Role

Barbara Gardella iD, Mattia Dominoni iD, Marianna Francesca Pasquali iD, Chiara Melito, Giacomo Fiandrino, Stefania Cesari iD, Marco La Verde iD, Arsenio Spinillo

Vaccines · 28.01.2023 · 11 (2) · 284

DOI: 10.3390/vaccines11020284 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vaccines, online erschienen am 28.01.2023. Verfasst von Barbara Gardella und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical, Surgical, Diagnostic and Paediatric Sciences, University of Pavia, 27100 Pavia, Italy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Low-grade cervical lesions have a high percentage of clearance in young women, even if 71–82% of low-grade intraepithelial lesion/atypical squamous cells of undetermined significance (LSIL/ASCUS) reported a High-Risk Human Papillomavirus (HR-HPV) infection, which correlates with an increased risk of Cervical Intraepithelial Neoplasia (CIN)2+. The immunogenic effect of the anti-HPV vaccine appears to be significant. The aim of the study is to evaluate the effect, two years after the diagnosis, of the anti-HPV preventive vaccination on patients with low-grade cervical lesions.

Methods

We collected clinical, colposcopic, histological, and virological data from patients aged 21–45 years who attended the colposcopy service of the department of Obsetrics and Gynecology of IRCCS Foundation Policlinico San Matteo, Pavia, Italy. In the 2005–2019 period and had a low-grade pap-smear.

Results

We enrolled 422 women consecutively, divided into two groups (vaccinated and not vaccinated) for the retrospective analysis. The rate of persistence and progression of CIN were higher in the not-vaccinated group (p = 0.019). The relative risk (RR) to develop CIN2+ during follow-up vs. the the CIN1 persistence was 1.005 (95% Confidence Interval—CI 0.961–1.051) vs. 0.994 (95% CI 0.994–1.018) for age, 3.472 (95% CI 1.066–11.320) vs. 1.266 (95% CI 0.774–2.068) for non-vaccinated, 0.299 (95% CI 0.088–1.018) vs. 0.518 (95% CI 0.242–1.109) for HIV status negative, respectively. Analyzing the time to negativity, the odds ratio (OR) was 1.012 (95% CI 1–1.024) for age and 1.591 (95% CI 1.223–2.069) for vaccination; on the other hand, considering the relationship between the time to negative and the HPV genotypes contained in the 9-valent HPV vaccines, the OR was 1.299 (95% CI 1.026–1.646) for at least one of these at recruitment and 0.631 (95% CI 0.471–0.846) at follow-up. Furthermore, the presence of at least one of the HPV genotypes targeted by the HPV nonavalent vaccine is a key indicator of the risk of progression to CIN2+: OR was 3.443 (95% CI 1.065–11.189) for the presence of at least one HPV genotype at enrollment and 5.011 (95% CI 1.899–13.224) for the presence of at least one HPV genotype at follow-up, respectively.

Conclusions

We reported in a retrospective study the benefit of anti-HPV vaccination in promoting negativity and increasing low-grade cervical lesions regression.

Schlagwörter

Stichwörter der Autor:innen

CINhuman papillomavirus virusvaccination

Autor:innen und Institutionen

  • Department of Clinical, Surgical, Diagnostic and Paediatric Sciences, University of Pavia, 27100 Pavia, Italy.
  • Department of Obstetrics and Gynecology, IRCCS Foundation Policlinico San Matteo, 27100 Pavia, Italy.
  • Anatomic Pathology Unit, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
  • Obstetrics and Gynecology Unit, Department of Woman, Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.

ORCID-Profile: Barbara Gardella, Mattia Dominoni, Marianna Francesca Pasquali, Stefania Cesari, Marco La Verde

Zitieren

APA

Gardella, B., Dominoni, M., Pasquali, M. F., Melito, C., Fiandrino, G., Cesari, S., La Verde, M., & Spinillo, A. (2023). Low-Grade Cervical Intraepithelial Neoplasia (CIN1) Evolution: Analysis of Opportunistic Preventive Vaccination Role. Vaccines, 11(2), 284. https://doi.org/10.3390/vaccines11020284

Vancouver

Gardella B, Dominoni M, Pasquali MF, Melito C, Fiandrino G, Cesari S, et al. Low-Grade Cervical Intraepithelial Neoplasia (CIN1) Evolution: Analysis of Opportunistic Preventive Vaccination Role. Vaccines. 2023;11(2):284. doi:10.3390/vaccines11020284

BibTeX
@article{Gardella2023,
  author = {Gardella, Barbara and Dominoni, Mattia and Pasquali, Marianna Francesca and Melito, Chiara and Fiandrino, Giacomo and Cesari, Stefania and La Verde, Marco and Spinillo, Arsenio},
  title = {Low-Grade Cervical Intraepithelial Neoplasia (CIN1) Evolution: Analysis of Opportunistic Preventive Vaccination Role},
  journal = {Vaccines},
  year = {2023},
  volume = {11},
  number = {2},
  pages = {284},
  doi = {10.3390/vaccines11020284}
}
Kostenlos starten →